Engineered Nanoplatelets for Enhanced Treatment of Multiple Myeloma and Thrombus.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 27626769.
- Also identified by DOI 10.1002/adma.201603463 and PMC identifier 5283718.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A platelet-membrane-coated biomimetic nanocarrier, which can sequentially target the bone microenvironment and myeloma cells to enhance the drug availability at the myeloma site and decrease off-target effects, is developed for inhibiting multiple myeloma growth and simultaneously eradicating thrombus complication.
Medical subject headings
- Biomimetic Materials
- Drug Carriers
- Multiple Myeloma
- Nanoparticles
- Thrombosis